K A Malle Life Sciences Private Limited
About K A Malle Life Sciences Private Limited
Data last updated:
K A Malle Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2011PTC220679.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rahul Radheshyam Bhomavat and Divyakumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 Krishna Dham L.S.Raheja Marg Raheja Township Malad(East), Mumbai, Maharashtra, India – 400097.
As per the financials filed for FY 2024, the company reported a revenue of ₹95,003, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹57,288 (net margin 60.3%) and EBITDA of ₹69,110 (EBITDA margin 72.7%). Revenue has declined at a compounded annual rate (CAGR) of 63% over three years.
Court records list 5 cases involving the company, including 5 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
K A Malle Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2 Krishna Dham L.S.Raheja Marg Raheja Township Malad(East), Mumbai, Maharashtra, India – 400097
- IndustryPharma, Drug Formulation & Development
To see the full contact details of K A Malle Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of K A Malle Life Sciences Private Limited
FY 2025 filings availableK A Malle Life Sciences Private Limited reported revenue of ₹95,003 (up 8513% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 63% over three years. EBITDA rose 441% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹69,110 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57,288 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 72.7% | ||||
| Net Profit Margin | 60.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of K A Malle Life Sciences Private Limited, buy the company report.
Board of directors of K A Malle Life Sciences Private Limited
K A Malle Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Radheshyam Bhomavat Also directs: Rahul Pharma Ltd, R S Residency Private Limited, Sai-Ashray Industries Limited and 3 more | Director | 08 Jun 2018 | 8 Years 5 Months | Current |
| Divyakumar Jain Also directs: Rahul Pharma Ltd, R S Residency Private Limited, Sai-Ashray Industries Limited and 3 more | Director | 10 Aug 2015 | 11 Years 3 Months | Current |
Peer comparison
K A Malle Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Retec Formulations Private Limited | ₹96,531 (FY 2025) | New Delhil, Delhi, India | ||||
| K A Malle Life Sciences Private Limitedthis company | ₹95,003 (FY 2024) | ₹57,288 | 60.3% | 8513.0% | Mumbai, Maharashtra, India | |
| Hazor Pharmaceuticals Private Limited | ₹93,979 (FY 2025) | -94.0% | Allahabad, Uttar Pradesh, India | |||
| Ligisan Pharmaceutical Private Limited | ₹93,791 (FY 2022) | -73.0% | Dadar West Mumbai, Maharashtra, India |
To see the full peer comparison of K A Malle Life Sciences Private Limited, buy the company report.
Auditor
K A Malle Life Sciences Private Limited is audited by Shankar & Kishor for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shankar & Kishor | FY 2023 | 112451W |
Shareholding
The shareholding of K A Malle Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of K A Malle Life Sciences Private Limited, buy the company report.
Legal cases
K A Malle Life Sciences Private Limited has 5 court cases on record: 5 filed by K A Malle Life Sciences. 1 case is pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 1 |
| District courts | 1 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed by the company against State Bank of India and 1 other | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| Bombay High Court | Writ petition | Filed by the company against State Bank of Mysore and 2 Ors | Disposed |
| Bombay High Court | Court case (NMW) | Filed by the company against The State of Mysore and 2 Ors | Disposed |
| Bombay High Court | Writ petition | Filed by the company against The State of Mysore and Ors | Disposed |
To see the full case history of K A Malle Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
K A Malle Life Sciences Private Limited has 5 MSME Form 1 returns on record between 2023 and 2024, listing 6 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Shankar & Kishor |
To see the full MSME payment records of K A Malle Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
No GST registration is on our record for K A Malle Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
K A Malle Life Sciences Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Rahul Radheshyam Bhomavat ceased to be Additional Director on 30 Sep 2018.
Frequently asked questions
K A Malle Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2011 (15+ years old) and is registered under CIN U74120MH2011PTC220679.
K A Malle Life Sciences has 2 current directors:
- Rahul Radheshyam Bhomavat - Director
- Divyakumar Jain - Director
The latest financial statements of K A Malle Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of K A Malle Life Sciences is U74120MH2011PTC220679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
K A Malle Life Sciences has 5 court cases on record: 5 filed by the company. 1 is pending. Most are in the high courts.
K A Malle Life Sciences was incorporated on 08 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of K A Malle Life Sciences by revenue are Retec Formulations Private Limited, Hazor Pharmaceuticals Private Limited, Ligisan Pharmaceutical Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rahul Radheshyam Bhomavat ceased to be Additional Director on 30 Sep 2018. Radheshyam Dagdulal Bhomavat ceased to be Director on 08 Jun 2018. Rahul Radheshyam Bhomavat was appointed as Director on 08 Jun 2018. K A Malle Life Sciences has 5 board changes on record in total.
K A Malle Life Sciences has 5 MSME Form 1 returns on record between 2023 and 2024, listing 6 overdue payments to 1 micro and small supplier. The latest return was filed on 27 Apr 2024.
The registered office of K A Malle Life Sciences is at 2 Krishna Dham L.S.Raheja Marg Raheja Township MaladEast, Mumbai, Maharashtra, India – 400097.
K A Malle Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of K A Malle Life Sciences is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
